|Day's range||5.52 - 5.52|
The Dow Jones Industrial Average (DJINDICES: ^DJI) lost ground on the day, but gains in the Nasdaq Composite (NASDAQINDEX: ^IXIC) left the S&P 500 (SNPINDEX: ^GSPC) little changed by day's end. After the closing bell, Zoom Video Communications (NASDAQ: ZM) and PetMed Express (NASDAQ: PETS) reported their latest financial results. Zoom's numbers were better than many had expected, while PetMed faced some challenges that kept its stock price down.
Kenneth Griffin's hedge fund Citadel Advisors bought additional shares of these high-yield dividend stocks in the first quarter.
While animal healthcare specialist PetMed Express (NASDAQ: PETS) advertises itself as "your trusted pet expert," the stock market wasn't trusting it as a solid investment this week. According to data compiled by S&P Global Market Intelligence, the company's shares fell by 13% for the week, largely due to its lackluster quarterly results. In the third quarter of its fiscal 2023, PetMed Express booked $58.9 million in net sales, a slight drop from the $60.7 million it made in the same quarter of the previous fiscal year.
Yahoo Finance Live’s Jared Blikre checks out several stocks trending in the after-hours trading session.
According to data from Infiniti Research, e-commerce is still expected to grow at a 27% compound annual growth rate (CAGR) through 2027 globally. In fact, 66% of Williams-Sonoma's sales come from e-commerce, and it has grown e-commerce sales at an impressive 9.7% CAGR over the past 20 years. With Williams-Sonoma's large online presence and extensive scale, it should benefit as e-commerce penetration in the sector grows.
The online pet pharmacy is in the early stages of expanding its sights, making it an interesting buy for risk-tolerant investors.
Procter & Gamble (NYSE: PG), 3M (NYSE: MMM), and PetMed Express (NASDAQ: PETS) are all due to report quarterly numbers in January, but they share more than that coincidence. The companies sell everyday items and offer above-average dividends. Investors have shied away from 3M this year because it is facing lawsuits regarding earplugs it sold to the military and environmental suits for its use of per- and polyfluoroalkyl substances (PFAS), which it said it is phasing out by 2025.
As a generic drugmaker, Teva Pharmaceutical Industries (NYSE: TEVA) has the trappings of a safe investment at first glance. Theoretically, demand for generic medications should be relatively consistent, and it's reasonable to believe that ongoing purchases of such drugs would make for a solid base of recurring revenue, which could increase over time. First, the company has a troublesome debt load of $21.6 billion that looms very large in comparison to its market cap of only $10.4 billion.
The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions. A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS). AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be.
PetMed (PETS) delivered earnings and revenue surprises of -51.85% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Amazon (AMZN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
American Pet Products Association, 70% of U.S. households own a pet, as quoted on Yahoo Finance. And Americans are splurging on their pets despite high inflation.
PetMed (PETS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.